News Breaks |
|
|
| September 26, 2012 |
| 08:05 EDT |  | TKMR, ALNY | Tekmira provides periodic update to shareholders regarding litigation
Tekmira Pharmaceuticals (TKMR) disclosed that its motions to dismiss for lack of standing and to disqualify Alnylam's counsel have been denied in the patent infringement lawsuit filed on Jan. 17, 2012 by Alnylam Pharmaceuticals (ALNY). and Isis Pharmaceuticals, Inc. in the U.S. District Court of Massachusetts, clearing the way for Tekmira to provide the customary answer to this complaint filed in January 2012. Alnylam added to the infringement action yesterday by suing Tekmira in Canada for infringing CA Patent No. 2,359,180. Tekmira CEO Mark J. Murray commented: "These patent infringement lawsuits are absolutely without merit. As the next step in these patent infringement proceedings, we will now file the procedurally appropriate answer to both complaints. It is important for our shareholders to understand that we are confident that Tekmira has access to the intellectual property we require for the development of our own products and for collaborations with our pharmaceutical partners," |
|
|
News For TKMR;ALNY From The Last 14 Days Check below for free stories on TKMR;ALNY the last two weeks. |
|
|
| May 24, 2013 |
| 10:04 EDT |  | ALNY | On The Fly: Analyst Initiation Summary
 Subscribe for More Information |
|
| 05:47 EDT | | ALNY | Alnylam initiated with a Buy at Deutsche Bank
Subscribe for More Information |
|
| May 22, 2013 |
| 11:53 EDT |  | ALNY | High option volume stocks: UAN MYL ALNY SKS XIDE
Subscribe for More Information |
|
| 07:35 EDT |  | TKMR | Bloom Burton & Co. to host a conference
Subscribe for More Information |
|
| 07:28 EDT | | ALNY | UBS to host a conference
Global Healthcare Services Conference is being held in New York on May 20-22 with webcasted company presentations to begin on May 22 at 8 am; not all company presentations may be webcasted. Webcast Link |
|
| May 17, 2013 |
| 08:04 EDT | | ALNY | Alnylam announces proof-of-concept data from RNAi program
Subscribe for More Information |
|
| May 16, 2013 |
| 07:29 EDT | | ALNY | Leerink to host a bus tour
Boston Biopharma Bus Tour travels throughout Boston on May 16-17. |
|
| May 14, 2013 |
| 08:43 EDT |  | ALNY | Alnylam has multiple upcoming positive catalysts, says JMP Securities
JMP Securities believes that Alnylam will have multiple positive data catalysts over the next two months. The firm thinks that upcoming data and presentations will enhance the company's positioning and perception of its pipeline, and it keeps an Outperform rating on the shares. |
|
|
|
|
|
